| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| CYTOTECT CP BIOTEST 100 U/ml | IMUNOGLOBULINA UMANA ANTI-CITOMEGALOVIRUS | SOL. PERF. | J06BB09 | W69368001 | BIOTEST PHARMA GMBH - GERMANIA | ||||||
| CYTOTECT CP BIOTEST 100 U/ml | IMUNOGLOBULINA UMANA ANTI-CITOMEGALOVIRUS | SOL. PERF. | J06BB09 | W69368002 | BIOTEST PHARMA GMBH - GERMANIA | ||||||
| DABIGATRAN ETEXILAT LABORATORIOS LICONSA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70890001 | LABORATORIOS LICONSA, S.A. - SPANIA | ||||||
| DABIGATRAN ETEXILAT LABORATORIOS LICONSA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70890002 | LABORATORIOS LICONSA, S.A. - SPANIA | ||||||
| DABIGATRAN ETEXILAT LABORATORIOS LICONSA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70890003 | LABORATORIOS LICONSA, S.A. - SPANIA | ||||||
| DABIGATRAN ETEXILAT LABORATORIOS LICONSA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70890004 | LABORATORIOS LICONSA, S.A. - SPANIA | ||||||
| DABIGATRAN ETEXILAT LABORATORIOS LICONSA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70890005 | LABORATORIOS LICONSA, S.A. - SPANIA | ||||||
| DABIGATRAN ETEXILAT LABORATORIOS LICONSA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70890006 | LABORATORIOS LICONSA, S.A. - SPANIA | ||||||
| DABIGATRAN ETEXILAT LABORATORIOS LICONSA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70890007 | LABORATORIOS LICONSA, S.A. - SPANIA | ||||||
| DABIGATRAN ETEXILAT LABORATORIOS LICONSA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70890008 | LABORATORIOS LICONSA, S.A. - SPANIA | ||||||
| DABIGATRAN ETEXILAT LABORATORIOS LICONSA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70890009 | LABORATORIOS LICONSA, S.A. - SPANIA | ||||||
| DABIGATRAN ETEXILAT LABORATORIOS LICONSA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70890010 | LABORATORIOS LICONSA, S.A. - SPANIA | ||||||
| DABIGATRAN ETEXILAT LABORATORIOS LICONSA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70890011 | LABORATORIOS LICONSA, S.A. - SPANIA | ||||||
| DABIGATRAN ETEXILAT LABORATORIOS LICONSA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70890012 | LABORATORIOS LICONSA, S.A. - SPANIA | ||||||
| DABIGATRAN ETEXILAT LABORATORIOS LICONSA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70890013 | LABORATORIOS LICONSA, S.A. - SPANIA | ||||||
| DABIGATRAN ETEXILAT LABORATORIOS LICONSA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70890014 | LABORATORIOS LICONSA, S.A. - SPANIA | ||||||
| DABIGATRAN ETEXILAT LABORATORIOS LICONSA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70890015 | LABORATORIOS LICONSA, S.A. - SPANIA | ||||||
| DABIGATRAN ETEXILAT LABORATORIOS LICONSA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70890016 | LABORATORIOS LICONSA, S.A. - SPANIA | ||||||
| DABIGATRAN ETEXILAT LABORATORIOS LICONSA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70890017 | LABORATORIOS LICONSA, S.A. - SPANIA | ||||||
| DABIGATRAN ETEXILAT LABORATORIOS LICONSA 150 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70891001 | LABORATORIOS LICONSA, S.A. - SPANIA |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman